Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029783 · ClinicalTrials.gov registry record · Phase 2
Efficacy of Distant Healing in Glioblastoma Treatment
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT00029783 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 150 participants.
The verdict
NCT00029783, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
This study will assess whether distant healing effects survival time and loss of function for glioblastoma patients.
Interventions
- PROCEDURE Distant Healing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2000-09 |
| Est. Completion | 2005-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00029783
The ClinicalTrials.gov registry entry for NCT00029783 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Distant Healing is the first listed.
NCT00029783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00029783 about?
NCT00029783 is a clinical study titled "Efficacy of Distant Healing in Glioblastoma Treatment". This study will assess whether distant healing effects survival time and loss of function for glioblastoma patients.
What is the current status of trial NCT00029783?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2000-09. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00029783?
The interventions under investigation include: Distant Healing (PROCEDURE).
Who is sponsoring clinical trial NCT00029783?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.